Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;380(3):223-32.
doi: 10.1007/s00210-009-0426-8. Epub 2009 Jun 2.

Adenosine A2A receptor deficient mice are partially resistant to limbic seizures

Affiliations

Adenosine A2A receptor deficient mice are partially resistant to limbic seizures

Malika El Yacoubi et al. Naunyn Schmiedebergs Arch Pharmacol. 2009 Sep.

Abstract

The neuromodulator adenosine, acting through activation of four defined metabotropic receptors called A(1), A(2A), A(2B) and A(3,) has been proposed as an endogenous anticonvulsant. Here, the consequences of deleting the adenosine A(2A) receptor have been examined in different experimental models of epilepsy. A(2A)R KO mice were not protected against seizures originating from brainstem structures, namely electroshock-induced seizures. The intensities of seizures induced by pentylenetetrazol or pilocarpine, as well as the percentages of convulsing mice, were significantly reduced in A(2A) receptor knockout (A(2A)R KO) animals. A(2A)R KO mice exhibited reduced pentylenetetrazol-induced kindled seizures, demonstrating an important role of the A(2A) receptor in the acquisition of kindling. These data suggest that adenosine stimulating A(2A) receptors modulates excitatory neurotransmission and exacerbates limbic seizures. It is therefore suggested that adenosine A(2A) receptor antagonists might offer protection from some epileptic syndromes.

PubMed Disclaimer

References

    1. Fed Proc. 1985 May;44(8):2425-31 - PubMed
    1. Neuroreport. 1998 Dec 1;9(17):3955-9 - PubMed
    1. Br J Pharmacol. 2003 Apr;138(7):1207-9 - PubMed
    1. Brain Res. 1992 Oct 16;593(2):257-64 - PubMed
    1. Neurochem Res. 2001 Sep;26(8-9):979-91 - PubMed

Publication types